How much revenue does Seegene make?

Seegene reported 474.23 billion KRW in revenue for fiscal year 2025, up 14.5% from 414.25 billion KRW in fiscal year 2024. In Q1 2026 revenue was 129.14 billion KRW.

Where does Seegene make most of its revenue?

South Korea: 54% of revenue by region in fiscal year 2025, followed by Europe (32%).

What companies are similar to Seegene?

Listed companies of a similar size in the same industry (DNA testing equipment) include Genomictree Inc. (228760.KQ), Gencurix Inc. (229000.KQ), Genesystem Co., Ltd. (363250.KQ), GeneMatrix Inc. (109820.KQ).

Seegene, Inc. (096530.KQ) Stock

About Seegene, Inc.

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection p...

At a glance

Seegene reported revenue of 474.23 billion KRW for fiscal year 2025, up 14.5% from fiscal year 2024, and net income of 48.27 billion KRW. In Q1 2026 (the quarter ended March 31, 2026) revenue was 129.14 billion KRW, up 11.3% from a year before. South Korea was its largest region in fiscal year 2025, with 54% of revenue.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.